TotalMarketCap

Market cap

$31.853 B

$84.41 +0.13%

Close of 9 Oct 2026

As of 9 Oct 2026, Dexcom (DXCM) has a market capitalization of $31.9B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.66B

#711 by revenue

Earnings

$836.3M

#441 by earnings

Shares outstanding

377,360,765

Latest filing cover page

P/E ratio

38.1

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →
  1. #5MedlineMDLN$47.0B
  2. #6ResmedRMD$31.9B
  3. #7DexcomDXCM$31.9B
  4. #8West Pharmaceutical ServicesWST$25.6B
  5. #9SolventumSOLV$14.7B

What if Dexcom were worth as much as…

Open the what-if tool →

Or at a round number

Where these numbers come from

Share counts and financials for Dexcom are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.